SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp rally is drawing attention after Morgan Stanley reiterated a bullish view, with SpaceXs proposed Florida gas pipeline for Starship fuel and the upcoming Flight 15 adding to the catalyst mix. Bulls are celebrating momentum and potential AI and Starship growth, while skeptics question the valuation and point to share unlocks and possible profit-taking.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Speculation around a reported Russian plague exposure is driving vaccine-sector interest in NVAX, alongside positive late-stage results from vaccine peer Vaxcyte; the outbreak reports remain unconfirmed, and traders disagree over how much they explain the move. Many also point to Novavaxs Sanofi and Takeda vaccine rollout and heavy short interest, fueling short-squeeze talk, while others warn the rally could fade.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

A suspected pneumonic-plague death at a Russian research institute has renewed interest in EBSs biodefense portfolio, alongside a sharp share-price move and heavier trading. Traders are debating whether the rally reflects stronger demand for biodefense products or could fuel a short squeeze; talk of upcoming contracts remains speculation.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is drawing attention amid a prolonged selloff and concerns that shares registered after the Serra Verde acquisition, alongside a securities shelf, could create dilution or selling pressure; some traders counter that the registration does not mean an immediate share sale. The debate is balanced by optimism about the companys government-backed domestic rare-earth strategy and potential supply-chain tailwinds, versus worries about execution, financing and persistent weakness.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definiums DT120 delivered another positive Phase 3 result in generalized anxiety disorder, with the Panorama study meeting its primary and key secondary endpoints and strengthening the companys case for an FDA filing. Traders welcomed the data but debated the stocks high valuation and commercialization challenges, with some describing the reaction as a sell-the-news move; no approval has been granted.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

FDA acceptance of Intellias lonvo-z application for priority review is driving attention, bringing its potential one-time treatment for hereditary angioedema closer to a regulatory decision and commercialization. Bulls see the milestone and broader gene-editing platform as significant validation, while skeptics point to weak share-price action, financing needs and the challenge of commercial adoption.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

TWSTs sharp rally and repeated 52-week highs are drawing attention, with traders linking momentum to its AI-enabled drug-discovery work, including the Lilly TuneLab collaboration, and improving growth expectations. Bulls describe a short squeeze, while skeptics point to valuation, insider selling and potential dilution as reasons for caution.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

PURR is drawing attention as a publicly traded proxy for Hyperliquids HYPE token, with traders reacting to HYPEs sharp rally and record-high levels and pointing to the companys growing token treasury and buyback strategy. Bulls anticipate PURR catching up or squeezing higher, while skeptics say share issuance and dilution may be holding it back despite HYPEs strength.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

Traders attribute MELIs sharp gain to Brazils election result and expectations of a more business-friendly government, with other Brazilian stocks rallying alongside it. Some question whether the political shift alone justifies the move; the discussion frames it as a regional macro catalyst rather than company news.

Roundhill ETF Trust - Roundhill Memory ETF

The discussion centers on whether AI-driven memory demand can sustain the sectors rally or whether easing memory prices, rising Chinese supply, and concerns about AI spending point to oversupply. Traders are split between bullish views on continued tight supply and bearish claims that the memory cycle has peaked.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Natural Alternatives Q4 Loss Widens Y/Y on Margin Pressure

NAII posts y/y sales growth in Q4'26, but a $10.4M impairment charge and factory underutilization weigh on profitability.

3 Microcaps for Your Watchlist

NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.

Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure

NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.

Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase 

NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.

Niche Focus & Regulation Shape the Future of Healthcare Firms

CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.

Zacks Initiates Coverage of NAII With Neutral Recommendation

Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates CFFI as "Neutral." Explore how Natural Alternatives' expansion, innovation and prudent management balance growth potential with margin and execution challenges in a dynamic supplement market.

Natural Alternatives Q4 Sales Rise 15% Y/Y, Loss Widens for FY25

NAII sales rise y/y in the fourth quarter of fiscal 2025, but higher charges and underused capacity widen loss.

Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. It operates through the Private-Label Contract Manufacturing, and Patent and Trademark Licensing segments. The Private-Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment is involved in direct raw material sales and royalty income from license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

Natural Alternatives International, Inc.

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$1.43
Prev Close	$1.48
Open	$1.52
Dividend Yield	0.00%
50-Day Moving Average	$2.03
Beta	0.41
Avg. Volume	18,877.08
PE Ratio	-0.42

52-Week High	$4.96
52-Week Low	$1.28
Market Capitalization	$9.29M
EPS (Annual)	-$3.43
Price to Book	0.18
Revenue Per Employee	$614,578.26

Feed

News

Sentiment

Earnings

Fundamentals

Info

NAII Fundamentals